A Novel EGFR Isoform Confers Increased Invasiveness to Cancer Cells

被引:25
作者
Zhou, Min [1 ]
Wang, Hai [1 ]
Zhou, Keke [2 ]
Luo, Xiaoying [1 ]
Pan, Xiaorong [1 ]
Shi, Bizhi [1 ]
Jiang, Hua [1 ]
Zhang, Jiqin [1 ]
Li, Kesang [1 ]
Wang, Hua-Mao [1 ]
Gao, Huiping [1 ]
Lu, Shun [3 ]
Yao, Ming [1 ]
Mao, Ying [2 ]
Wang, Hong-Yang [1 ,4 ]
Yang, Shengli [1 ]
Gu, Jianren [1 ]
Li, Chuanyuan [5 ]
Li, Zonghai [1 ]
机构
[1] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Hosp, Shanghai Canc Inst,Sch Med, Shanghai 200032, Peoples R China
[2] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China
[3] Shanghai Jiao Tong Univ, Chest Hosp, Shanghai Lung Tumor Clin Med Ctr, Shanghai 200032, Peoples R China
[4] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Signal Transduct, Shanghai, Peoples R China
[5] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC USA
基金
中国国家自然科学基金;
关键词
GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; LUNG-CANCER; EXPRESSION; PROGNOSIS; TRANSCRIPTION; METASTASIS; ACTIVATION; THERAPY; GLIOMAS;
D O I
10.1158/0008-5472.CAN-13-0194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As a validated therapeutic target in several human cancers, the EGF receptor (EGFR) provides a focus to gain deeper insights into cancer pathophysiology. In this study, we report the identification of a naturally occurring and widely expressed EGFR isoform termed EGFRvA, which substitutes a Ser/Thr-rich peptide for part of the carboxyl-terminal regulatory domain of the receptor. Intriguingly, EGFRvA expression relates more closely to histopathologic grade and poor prognosis in patients with glioma. Ectopic expression of EGFRvA in cancer cells conferred a higher invasive capacity than EGFR in vitro and in vivo. Mechanistically, EGFRvA stimulated expression of STAT3, which upregulated heparin-binding EGF (HB-EGF). Reciprocally, HB-EGF stimulated phosphorylation of EGFRvA at Y845 along with STAT3, generating a positive feedback loop that may reinforce invasive function. The significance of EGFRvA expression was reinforced by findings that it is attenuated by miR-542-5p, a microRNA that is a known tumor suppressor. Taken together, our findings define this newfound EGFR isoform as a key theranostic molecule. (C)2013 AACR.
引用
收藏
页码:7056 / 7067
页数:12
相关论文
共 40 条
[1]   c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function [J].
Biscardi, JS ;
Maa, MC ;
Tice, DA ;
Cox, ME ;
Leu, TH ;
Parsons, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :8335-8343
[2]   MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma [J].
Bray, Isabella ;
Tivnan, Amanda ;
Bryan, Kenneth ;
Foley, Niamh H. ;
Watters, Karen M. ;
Tracey, Lorraine ;
Davidoff, Andrew M. ;
Stallings, Raymond L. .
CANCER LETTERS, 2011, 303 (01) :56-64
[3]  
Bredel M, 1999, CLIN CANCER RES, V5, P1786
[4]   STAT3 as a Central Regulator of Tumor Metastases [J].
Devarajan, Eswaran ;
Huang, Suyun .
CURRENT MOLECULAR MEDICINE, 2009, 9 (05) :626-633
[5]   Epidermal growth factor receptor inhibits colitis-associated cancer in mice [J].
Dube, Philip E. ;
Yan, Fang ;
Punit, Shivesh ;
Girish, Nandini ;
McElroy, Steven J. ;
Washington, M. Kay ;
Polk, D. Brent .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (08) :2780-2792
[6]   Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group) [J].
Elie, C ;
Geay, JF ;
Morcos, M ;
Le Tourneau, A ;
Girre, V ;
Broët, P ;
Marmey, B ;
Chauvenet, L ;
Audouin, J ;
Pujade-Lauraine, E ;
Camilleri-Broët, S .
BRITISH JOURNAL OF CANCER, 2004, 91 (03) :470-475
[7]   ALTERATIONS OF HUMAN PLACENTAL EPIDERMAL GROWTH-FACTOR RECEPTOR IN INTRAUTERINE GROWTH-RETARDATION [J].
FONDACCI, C ;
ALSAT, E ;
GABRIEL, R ;
BLOT, P ;
NESSMANN, C ;
EVAINBRION, D .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1149-1155
[8]   Should we be surprised at the paucity of response to EGFR inhibitors? [J].
Gusterson, Barry A. ;
Hunter, Keith D. .
LANCET ONCOLOGY, 2009, 10 (05) :522-527
[9]   Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer [J].
Haura, EB ;
Turkson, J ;
Jove, R .
NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06) :315-324
[10]   Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead [J].
Huang, Tiffany T. ;
Sarkaria, Shawn M. ;
Cloughesy, Timothy F. ;
Mischel, Paul S. .
NEUROTHERAPEUTICS, 2009, 6 (03) :500-512